Evolus Inc (EOLS) is a Healthcare · Drug Manufacturers - Specialty & Generic company listed on NASDAQ. Price $7.86 (-1.87%), Market cap $0.44B, 52-week low–high $3.94 ~ $10.24.
Evolus, Inc., a performance beauty company, delivers products in the cash-pay aesthetic market in the United States, Canada, Europe, and Australia. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults; and Evolysse, a collection of injectable hyaluronic acid gels, which includes various products, such as mid face, nasolabial folds, lips and eyes. The company was incorporated in 2012 and is headquartered in Newport Beach, California.
Financial statements, price targets, institutional (13F) holdings and related news for Evolus Inc are updated in real time on BlackAll Trade.
Evolus Inc trades at $7.86 (-1.87%). Real-time quotes and charts are available on BlackAll Trade.
Evolus Inc has a market cap of about $0.44B.
Evolus, Inc., a performance beauty company, delivers products in the cash-pay aesthetic market in the United States, Canada, Europe, and Australia. It offers Jeuveau, a proprietary 900 kilodalton puri